Summarize this blog post with:
TL;DR: Indian pharmaceutical companies face a demanding intersection of regulatory compliance, multi-site manufacturing, and global export requirements. NetSuite's pharma-relevant modules cover lot and serial number traceability, quality management, multi-site inventory, and GST compliance in one system. This post covers how it applies to the specific operational and regulatory context of Indian pharma in 2026.
Running a pharmaceutical company in India in 2026 means operating at the intersection of two sets of intensifying requirements. On one side, CDSCO, India's Central Drugs Standard Control Organisation, and the state-level drug control authorities that enforce manufacturing standards under Schedule M, received a comprehensive update in 2023 aligning Indian GMP requirements more closely with WHO GMP guidelines. On the other hand, the export regulatory requirements of the markets Indian pharma companies supply, from US FDA-regulated APIs to EU-GMP-required finished dosage forms for European distributors.
The ERP system a pharma company runs is not peripheral to this compliance environment. It is where lot records are maintained, where quality holds are applied and released, where batch manufacturing records are generated, and where the traceability that regulators require in an inspection is either accessible or painfully reconstructed.
This post is about what NetSuite specifically offers for Indian pharmaceutical businesses, without overstating it. It is a capable cloud ERP with strong pharma-relevant functionality. It is not a dedicated life sciences QMS platform. Understanding where it fits and where it needs integration with specialist tools is important for any Indian pharma company evaluating it.
Schedule M compliance under the Drugs and Cosmetics Act requires Indian manufacturers to maintain complete records of raw material receipt, testing, approval, and usage. Batch manufacturing records, batch packaging records, and batch release authorisation must be traceable and available on demand during regulatory inspections.
The 2023 Schedule M amendments raised the bar on documentation requirements, particularly for small and medium pharma manufacturers who had previously operated under less formalised record-keeping practices. Many of these businesses were maintaining batch records in physical files, Excel, or disconnected systems. The amendment created urgency around digitising these records in a system that could survive a CDSCO inspection.
For export-oriented manufacturers, the requirements go further. The US FDA expects electronic batch records and the ability to trace any finished product batch back through every raw material lot used in its production. EU GMP requires similar traceability as part of Annex 11 compliance for computerised systems. APEDA registration for API exporters carries its own documentation requirements.
GST e-invoicing, e-way bill generation for pharmaceutical goods movements, and TDS compliance add the statutory layer that any Indian business must manage, but in pharma the intersection of goods movement documentation with batch traceability creates additional complexity.
Lot and serial number traceability is native to NetSuite's inventory module. Every item in NetSuite can be tracked by lot number from receipt of raw materials through the manufacturing process to finished goods dispatch. A complete lot genealogy report, showing which raw material lots from which suppliers went into which finished product batches, is accessible directly from the system.
This matters directly for CDSCO inspections and for managing regulatory recalls. If a raw material lot from a specific supplier is identified as compromised, NetSuite can identify every finished product batch that used material from that lot within minutes, enabling a targeted response rather than a broad precautionary recall.
Multi-site inventory management is relevant for pharma companies operating multiple manufacturing plants, contract manufacturing sites, or storage depots. NetSuite's inventory module tracks stock across locations with full lot-level visibility, and inter-site transfers maintain the chain of custody documentation that GMP requires.
Quality management within NetSuite covers quality holds on lots, quarantine statuses, and inspection workflows. Incoming raw materials can be placed in quarantine automatically on receipt, moved to approved status following quality testing, and linked to the test results that authorise release. The same workflow applies to in-process and finished goods quality holds.
Work orders and manufacturing execution in NetSuite record the materials consumed, the operations performed, and the equipment used in production, creating a digital manufacturing record that maps to the batch manufacturing record required under Schedule M. For manufacturers exploring this further, our overview of discrete manufacturing ERP covers how NetSuite handles production-floor workflows in detail. The depth of this record depends on how thoroughly the manufacturing workflow is configured, which is an implementation task, not a default out-of-the-box state.
NetSuite is not a purpose-built pharmaceutical QMS. For businesses that need full electronic batch record (EBR) management with 21 CFR Part 11-compliant electronic signatures, deviation management workflows, CAPA tracking, and validated system documentation for US FDA submission, NetSuite needs to be integrated with a specialist QMS platform such as Veeva Vault, MasterControl, or ETQ.
NetSuite does have audit trail functionality and access control capabilities that support the intent of 21 CFR Part 11, but achieving full compliance for FDA-regulated systems typically requires additional configuration and validation documentation that goes beyond standard NetSuite implementation.
For Indian manufacturers currently focused on CDSCO compliance and domestic market operations, NetSuite's built-in capabilities are often sufficient. For those targeting US FDA registration or EU GMP certification, a hybrid architecture with NetSuite as the ERP backbone and a validated QMS for regulated documentation is the more appropriate approach. SaasWorx has implemented this architecture for Indian pharma clients and can guide the integration design.
Pharmaceutical products carry specific GST rate structures, and e-invoicing requirements apply to pharma companies that cross the mandatory threshold. NetSuite's Oracle India localisation module handles HSN code management, GST rate application at product level, GSTR-1 and GSTR-3B generation, and e-invoicing through the IRP portal.
For pharma companies with both GST-exempt and GST-applicable products in their catalogue, the item-level configuration of GST rates in NetSuite needs to reflect the current rate structure accurately. This is a configuration task during implementation but also an ongoing maintenance task as GST rate changes occur.
Export documentation for pharmaceutical API and finished dosage form exports, including shipping bill integration and export invoice formatting, is handled within NetSuite's order management module with appropriate configuration.
A typical NetSuite implementation for an Indian pharmaceutical company covers inventory with full lot tracking, quality management configuration for quarantine and release workflows, manufacturing work orders with bill of materials linked to finished product batches, procurement with raw material lot receipt and testing documentation, financial management with GST compliance, and reporting covering lot genealogy, quality hold status, and inventory valuation by lot.
Implementation typically takes four to six months for a mid-sized pharma manufacturer. The most time-intensive components are mapping the existing batch record documentation process to the NetSuite workflow model and validating the lot traceability configurations against actual production scenarios.
Change management for the production and quality teams is as important as the technical configuration. QA managers and production supervisors who have worked with physical batch records for years need structured training on the digital equivalents in NetSuite. Our work with clients across manufacturing industry solutions consistently shows that structured onboarding at the floor level determines how quickly the compliance benefits of the system are realised.
Can NetSuite manage lot traceability for pharmaceutical manufacturing?
Yes, NetSuite's inventory module supports full lot and serial number traceability from raw material receipt through manufacturing to finished goods dispatch. Lot genealogy reports can trace every raw material lot used in a finished product batch, supporting CDSCO inspection requirements and enabling targeted recall management.
Does NetSuite comply with Schedule M requirements for Indian pharma manufacturers?
NetSuite supports the documentation and traceability requirements of Schedule M through its lot tracking, manufacturing work order, and quality management modules. Complete compliance depends on how thoroughly the system is configured to capture batch manufacturing record data. For Schedule M compliance, implementation by a partner with pharma industry experience is important.
Is NetSuite suitable for US FDA-regulated pharmaceutical manufacturing?
For basic lot traceability and ERP functions, NetSuite provides a solid foundation. However, full 21 CFR Part 11 compliance for electronic batch records and validated QMS requirements typically requires integration with a specialist pharmaceutical QMS platform. SaasWorx can design the hybrid architecture that uses NetSuite as the ERP backbone alongside a validated QMS for regulated documentation, explore our NetSuite implementation services to understand how we approach this for regulated manufacturers.
How does NetSuite handle GST compliance for pharmaceutical products in India?
NetSuite's Oracle India localisation module manages HSN code assignment, GST rate application at item level, GSTR-1 and GSTR-3B generation, and e-invoicing through the IRP portal. Pharmaceutical products with specific GST rate structures including exemptions are configurable at the item master level.
The Indian pharmaceutical industry's compliance requirements are not getting simpler. CDSCO enforcement has increased, Schedule M requirements have been updated, and the documentation standard for export registration continues to rise. Running these requirements across physical files, Excel, and disconnected systems is not a sustainable model for a business of any meaningful scale.
NetSuite provides the lot traceability, quality management workflow, and statutory compliance infrastructure that mid-market Indian pharma companies need in a single cloud system. The implementation requires industry-specific expertise to configure correctly, but once done, the operational and compliance visibility it provides is substantial.
SaasWorx has implemented NetSuite for Indian life sciences and pharmaceutical businesses. If you are evaluating ERP for a pharma operation, we are happy to walk through what a fit-for-purpose configuration looks like for your specific manufacturing profile.
